scispace - formally typeset
C

Cláudia Machado Siqueira

Researcher at Universidade Federal de Minas Gerais

Publications -  10
Citations -  163

Cláudia Machado Siqueira is an academic researcher from Universidade Federal de Minas Gerais. The author has contributed to research in topics: Dyslexia & Child development. The author has an hindex of 5, co-authored 10 publications receiving 133 citations.

Papers
More filters
Journal ArticleDOI

Mau desempenho escolar: uma visão atual

TL;DR: A revisao atualizada sobre o tema de mau desempenho escolar for profissionais da area de saude e educacao is presented in this paper.
Journal ArticleDOI

Poor school performance: an updated review

TL;DR: This study aims to develop a comprehensive review on the issue of poor school performance for professionals in both health and education areas and presents updated data on key aspects of neurobiology, epidemiology, etiology, clinical presentation, comorbidities and diagnosis, early intervention and treatment of the major pathologies comprised.
Journal ArticleDOI

Adaptação Transcultural do instrumento de vigilância do desenvolvimento infantil “Survey of Wellbeing of Young Children (SWYC)” no contexto brasileiro

TL;DR: In this paper, a survey of well-being of young children (SWYC) was conducted in Brazil, with 65 criancas menores of 65 meses, and a set of questionarios -Developmental Milestones, Parent's Observations of Social Interactions (POSI), BPSC, Preschool Pediatric Symptom Checklist (PPSC), and Family Questions -were investigated.
Journal ArticleDOI

Rapid Naming in Brazilian Students with Dyslexia and Attention Deficit Hyperactivity Disorder

TL;DR: This ability to identify and recognize a given item by the activation and concomitant articulation of its name tended to improve with age, which was not the case, however, with schoolchildren who had ADHD or dyslexia.
Journal ArticleDOI

Stroke-like encephalopathy following high-dose intravenous methotrexate in an adolescent with osteosarcoma: a case report

TL;DR: Methotrexate (MTX) is an important cytostatic drug in cancer chemotherapy and the most widely used antimetabolite in childhood cancers and can cause acute, subacute and chronic neurological complications.